<?xml version="1.0" encoding="iso-8859-1"?><CoCoMacExport xmlns="http://www.cocomac.org" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.cocomac.org http://www.cocomac.org/cocomac.xsd">
<Header>
<Creator>CoCoMac-Online</Creator>
<CoCoMacVersion>20</CoCoMacVersion>
<ExportDate>2013-10-30T15:22:38+01:00</ExportDate>
<DataType>BibliographicData</DataType>
<DataType>BrainMapData</DataType>
<Feedback>
<Query>
<HttpString>Search=LITERATURE&amp;OutputType=XML_BROWSER&amp;SearchString=('S01') [LITID]&amp;Details=</HttpString>
<SearchString>('S01') [LITID]</SearchString>
<SqlString>SELECT  Top 32767  ID,Literature FROM Literature WHERE  (Literature ='S01') </SqlString>
</Query>
<Results>1</Results>
</Feedback>
<Comments>CocoMac XML Output</Comments>
</Header>
<BibliographicData>
<ID>S01</ID>
<Authors>
<Author>
<Initials>S</Initials>
<LastName>Shipp</LastName>
</Author>
</Authors>
<Title>Corticopulvinar connections of areas V5, V4, and V3 in the macaque monkey: a dual model of retinal and cortical topographies</Title>
<Year>2001</Year>
<Journal>
<JournalName>J. Comp. Neurol.</JournalName>
<Volume>439</Volume>
<Pages>469-490</Pages>
<PubMedID>11596067</PubMedID>
</Journal>
</BibliographicData>
<MapData>
<BrainMap>
<IDBrainMap>S01</IDBrainMap>
<BrainSiteList>
<BrainSite>
<ID_BrainSite>S01-DP</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>DP</Acronym>
<FullName>Dorsal prelunate gyrus</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-MST</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>MST</Acronym>
<FullName>Medial superior temporal area</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V1</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V1</Acronym>
<FullName>Visual area 1</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V1/V2</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V1/V2</Acronym>
<FullName>Visual area 1 and visual area 2</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V2</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V2</Acronym>
<FullName>Visual area 2</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V3</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V3</Acronym>
<FullName>Visual area 3</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V4</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V4</Acronym>
<FullName>Visual area 4</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V4t</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V4t</Acronym>
<FullName>V4 transitional area</FullName>
<DefType>A</DefType>
</BrainSite>
<BrainSite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteClass>Area_IsoCtx</SiteClass>
<Acronym>V5</Acronym>
<FullName>Visual area 5</FullName>
<DefType>A</DefType>
</BrainSite>
</BrainSiteList>
</BrainMap>
</MapData>
<ExperimentalData>
<ID_Literature>S01</ID_Literature>
<Method>
<TracerSubstance>
<ID_Tracer>WGA-HRP</ID_Tracer>
<FullName>Horseradish peroxidase, conjugated to wheat germ agglutinin</FullName>
<Anterograde>true</Anterograde>
<Retrograde>true</Retrograde>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>?</InjectionMethod>
<SurvivalTime>36-60 h</SurvivalTime>
<Thickness_Sections>50, 60, 30</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>?</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca fascicularis</MacaqueSpecies>
<Sex>?</Sex>
<Number>?</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 477</TextPageNumber>
<FigureNumber>Fig. 7</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V1/V2</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 475</TextPageNumber>
<FigureNumber>Fig. 4</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 477</TextPageNumber>
<FigureNumber>Fig. 7</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V3</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 473</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 477</TextPageNumber>
<FigureNumber>Fig. 7</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V3</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<AffectedSites>
<ID_BrainSite>S01-MST</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</AffectedSites>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>F</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 477</TextPageNumber>
<FigureNumber>Fig. 7</FigureNumber>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V4</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<AffectedSites>
<ID_BrainSite>S01-DP</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</AffectedSites>
<Volume>0.5</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Figs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V4</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.5</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Fifs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V4</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.06</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Figs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V3</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.12</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Figs. 3, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V3</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.05-0.1</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 473</TextPageNumber>
<FigureNumber>Fig. 3</FigureNumber>
</Reference>
</Injection>
</Method>
<Method>
<TracerSubstance>
<ID_Tracer>TAA</ID_Tracer>
<FullName>Tritiated Amino Acids</FullName>
<Anterograde>true</Anterograde>
<Retrograde>false</Retrograde>
<RadioactiveTracer>
<TracerSubstance>[3H]-leucine</TracerSubstance>
<Activity>186</Activity>
<SpecificActivity>300</SpecificActivity>
<Ratio>-</Ratio>
</RadioactiveTracer>
</TracerSubstance>
<BilateralUse>false</BilateralUse>
<InjectionMethod>?</InjectionMethod>
<SurvivalTime>36-60 h</SurvivalTime>
<Thickness_Sections>50, 60, 30</Thickness_Sections>
<Animals>
<Nbr_AllAnimals>?</Nbr_AllAnimals>
<Nbr_AllFemaleAnimals>?</Nbr_AllFemaleAnimals>
<AgeRange>?</AgeRange>
<WeightRange>?</WeightRange>
<Details>
<MacaqueSpecies>Macaca fascicularis</MacaqueSpecies>
<Sex>?</Sex>
<Number>?</Number>
</Details>
</Animals>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<AffectedSites>
<ID_BrainSite>S01-MST</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</AffectedSites>
<AffectedSites>
<ID_BrainSite>S01-V4t</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</AffectedSites>
<Volume>0.8</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Figs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.8</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Figs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V5</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>C</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.8</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Fifs. 2, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
<Injection>
<InjectedBrainsite>
<ID_BrainSite>S01-V4</ID_BrainSite>
<SiteType>Area_IsoCtx_2D</SiteType>
<Hemisphere>?</Hemisphere>
<PDC_Site>A</PDC_Site>
<Extent>
<EC>X</EC>
<PDC_EC>-</PDC_EC>
</Extent>
</InjectedBrainsite>
<Volume>0.8</Volume>
<Concentration>?</Concentration>
<MethodicalProblems>false</MethodicalProblems>
<Reference>
<ID_Literature>S01</ID_Literature>
<TextPageNumber>p. 471</TextPageNumber>
<FigureNumber>Fifs. 3, 4</FigureNumber>
<Quotation>&amp;quot;Four brains were dual-injection cases, being additionally injected with tritiated amino acids (TAA) in the same hemisphere; three of these (cases SP40, SP42, and SP43) had WGA-HRP placed in V4 and TAA placed in V5. The fourth (case SP44) received TAA in V4 and HRP-Wga in area V3.&amp;quot; p. 471</Quotation>
</Reference>
</Injection>
</Method>
</ExperimentalData>
</CoCoMacExport>
